New China Life Insurance Co Ltd Class H
01336: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$57.00 | Vwyvk | Clfmrsrp |
New China Life’s 2022 NBV Growth Weaker Than Peers on Sharp Contraction in Agent Headcount
Business Strategy and Outlook
NCI differentiates with a focus on the underserved health insurance business to drive value-oriented growth. However, facing rising industrywide headwinds and senior management changes, it seems to have come to a crossroad over further growth.